Piramal Pharma stock in focus on $80 million expansion plan for Kentucky injectables facility

Piramal Pharma Solutions, is investing $80 million to expand its Lexington facility, doubling capacity by Q1 2027 to meet growing injectables demand, supporting its ADC manufacturing program.